You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 248 No. 11, September 17, 1982 TABLE OF CONTENTS
  JAMA
  •  Online Features
  BRIEF REPORTS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Severe von Willebrand's Disease During Labor and Delivery

Richard A. Lipton, MD; Jahangir Ayromlooi, MD; Barry S. Coller, MD

JAMA. 1982;248(11):1355-1357.


Abstract

In pregnant women with severe von Willebrand's disease, the prepartum period should include monitoring for a rise in factor VIII-related activities (factor VIII coagulant activity [factor VIII:C], factor VIII-related antigen [VIII R:Ag], and factor VIII ristocetin cofactor [factor VIII R:Cof]). Two women whose pregnancies were so monitored were delivered of normal infants: one by cesarean section and one by vaginal delivery. The failure of factor VIII R:Ag or factor VIII R:Cof to rise above a level of 50% at term in the woman who delivered vaginally predicted hemostatic difficulty during the postpartum period. She was, therefore, treated with cryoprecipitate. In the woman who gave birth by cesarean section, although all factor VIII-related activities rose into the normal range, the additional surgical trauma anticipated in cesarean section prompted the use of cryoprecipitate as well.

(JAMA 1982;248:1355-1357)



Author Affiliations

From the Departments of Medicine (Dr Lipton) and Obstetrics and Gynecology, Section of Maternal and Fetal Medicine (Dr Ayromlooi) at the Long Island Jewish-Hillside Medical Center, New Hyde Park, NY; and the Department of Medicine, the State University of New York at Stony Brook, Long Island (Dr Coller).


Footnotes

Reprint requests to Hemophilia Treatment Program, Long Island Jewish-Hillside Medical Center, New Hyde Park, NY 11042 (Dr Lipton).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Medical Illness and Pregnancy: An Annotated Bibliography of Recent Literature
ELLIOT et al.
ANN INTERN MED 1983;99:131-137.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.